IBM has disclosed details of a critical security flaw in API Connect that could allow attackers to gain remote access to the application. The vulnerability, tracked as CVE-2025-13915, is rated 9.8 out ...

OpenAI has sent out emails notifying API customers that its chatgpt-4o-latest model will be retired from the developer platform in mid-February 2026,. Access to the model is scheduled to end on ...

Currently The Flowchart controller is not exposed to the scripting. this makes it really inconvenient from projects that are focus on pure javascript/typescript and forces the use wrapper function in ...

Microsoft Incident Response – Detection and Response Team (DART) researchers uncovered a new backdoor that is notable for its novel use of the OpenAI Assistants Application Programming Interface (API) ...

In a breakthrough announcement, OpenAI recently introduced the ChatGPT API to developers and the public. Particularly, the new “gpt-3.5-turbo” model, which powers ChatGPT Plus has been released at a ...

API manufacturing has many major challenges. However, implementing the right flow chemistry approaches can make a significant impact for driving success. Join us for this valuable webinar to learn ...

Our API key for the TomTom API can be found in one of the commits. To make sure only we can use the TomTom API with our key, we should generate a new API key. No code changes have to be made for this ...

FederalRegister.gov retrieves relevant information about this document from Regulations.gov to provide users with additional context. This information is not part of the official Federal Register ...

Third-party app developers won’t be able to access Bing Search data from August 11th onwards. Third-party app developers won’t be able to access Bing Search data from August 11th onwards. is a senior ...

OpenAI will soon retire GPT-4, an AI model it launched over two years ago, from ChatGPT, according to a changelog posted on Thursday. Effective April 30, GPT-4 will be “fully replaced” by GPT-4o, the ...

The pharmaceutical services provider Sterling Pharma Solutions will produce hypericin, the active ingredient in an oncology drug being developed by the biotech firm Soligenix. Sterling says it will ...